CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	12 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities:
Net loss	$ (12,855,767)	$ (12,175,979)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	633,328	706,496
Impairment expense	253,977
Stock based compensation expense	3,257,305	2,038,830
Loss on sale of property and equipment		5,520
Common stock issued for consulting services		78,130
Security deposit write-off		10,000
Provision for bad debts	423,920	116,825
Change in operating assets and liabilities:
Accounts receivable	3,084,311	(2,597,203)
Inventories	(28,709)	16,209
Prepaid expenses, other current assets and deposits	(167,448)	(297,759)
Accounts payable and accrued liabilities	(610,504)	(253,333)
Deferred revenue	(1,469,597)	2,455,537
Net cash used in operating activities	(7,479,184)	(9,896,727)
Cash flows from investing activities:
Proceeds from sale of property and equipment		5,500
Purchases of intangible assets		(112,403)
Purchases of property and equipment	(145,436)	(672,859)
Net cash used in investing activities	(145,436)	(779,762)
Cash flows from financing activities:
Net proceeds from sale of common stock and warrants	6,105,127	7,853,155
Proceeds from exercise of warrants		4,410
Deferred offering costs		(13,986)
Purchase and cancellation of previously issued warrants	0	0
Net cash provided by financing activities	6,105,127	7,843,579
Net decrease in cash and cash equivalents	(1,519,493)	(2,832,910)
Cash and cash equivalents at beginning of year	4,479,274	7,312,184
Cash and cash equivalents at end of year	2,959,781	4,479,274
Supplemental Disclosures of Cash Flow Information:
Cash paid during year for interest	0	0
Cash paid during year for income taxes	0	0
Non-cash investing and financing transactions:
Property and equipment acquired, and included in accounts payable		10,767
Common stock issued for cashless exercise of options		$ 49
Reclassification of deferred offering costs to additional paid in capital	$ 13,986